Landos Biopharma completed a series A financing round raising $10 million.
Here's what you should know:
1. Perceptive Advisors led the financing round, serving as the exclusive investor.
2. Landos is a pharmaceutical pipeline developing treatments for autoimmune diseases, specifically for Crohn's disease and ulcerative colitis.
3. The funding will be used to advance the development of BT-11, specifically to advance the product through its initial phase I clinical testing.